How sneezing hamsters sparked a COVID outbreak in Hong Kong
On Feb. 4, 2022, pet hamsters probably carried the Delta variant of SARS-CoV-2 into Hong Kong and sparked…
UK MHRA granted Conditional Marketing Authorization for Novavax COVID-19 vaccine in Great Britain
On Feb. 3, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency had granted conditional marketing…
FDA approved first generic of Restasis
On Feb. 2, 2022, the U.S. Food and Drug Administration announced it had approved the first generic of…
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Life Science News | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Cancer MoonShot program reignited
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
Pfizer and BioNTech initiated rolling submission for EUA of COVID-19 vaccine in children 6 months through 4 years of age
On Feb. 1, 2022, Pfizer and BioNTech announced that following a request from the U.S. Food and Drug…
InteliSwabï¾® COVID-19 rapid tests receive U.S. FDA authorization for pediatric use
On Jan. 31, 2022, OraSure Technologies announced that its InteliSwabï¾® COVID-19 rapid tests had been authorized by the…
Veru announced FDA Grant of Fast Track Designation for Sabizabulin for treatment of hospitalized COVID-19 patients
On Jan. 31, 2022, Veru announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
WHO and Viamo provided critical access to COVID-19 information to the next billion digital users via their mobile phones
On Jan. 28, 2022, the WHO announced that COVID-19 information had reached 1,292,209 people through Viamoï¾’s 3-2-1 Platform…
Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
On Jan. 27, 2022, NIAID announced that a clinical trial found that the combination of remdesivir plus a…
COVID-19 | FDA | Life Science History | NIH
Mix-and-match trial found additional dose of COVID-19 vaccine safe, immunogenic
On Jan. 26, 2022, the NIH announced that adults who had previously received a full regimen of any…
Scientists regrow frogï¾’s lost leg
On Jan. 26, 2022, scientists at Tufts and Harvard Universityï¾’s Wyss Institute reported they were able to trigger…
Report published in PNAS detailed spread and evolution of SARS-CoV-2 in white-tailed deer across the U.S.
On Jan. 25. 2022, a report published in PNAS provided strong evidence of extensive SARS-CoV-2 infection of white-tailed…
Pfizer and BioNTech initiated study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
On Jan. 25, 2022, Pfizer and BioNTech announced the initiation of a clinical study to evaluate the safety,…
USDA announced study with zoos and aquariums to identify animal species susceptible to SARS-CoV-2
On Jan. 25, 2022, the U.S. Department of Agricultureï¾’s National Veterinary Services Laboratories announced a study with zoos…
University of Missouri researchers identified mutations of Delta, Delta Plus variants
On Jan. 25, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Evolution of CRISPR
The Evolution of CRISPR illustrates its climb out of the primordial ocean on the backs of eukaryotic cells…
Mixed vaccine schedules offered strong booster responses after two doses of CoronaVac vaccine
On Jan. 24, 2022, the University of Oxford announced that a third booster dose of either the ChAdOx1…
FDA approved Veklury (Remdesivir) for treatment of non-hospitalized patients at high risk for COVID-19 disease progression
On Jan. 20, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration had granted expedited approval…
NIH awarded $170 million for precision nutrition study
On Jan. 20, 2022, the National Institutes of Health announced it was awarding $170 million over five years,…
Humanigen announced peer-reviewed publication demonstrating clinical and economic benefits of lenzilumab
On Jan. 18, 2021, Humanigen announced a peer-reviewed publication in the Journal of Medical Economics citing the clinical…
Brazilian Health Regulatory Agency authorized Sorrento phase 2 clinical trial of COVI-MSC in COVID-19l long-hauler patients
On Jan. 18, 2022, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
Merck and Ridgeback announced supply agreement with UNICEF for molnupiravir, investigational oral antiviral COVID-19 medicine
On Jan. 18, 2022, Merck and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the…
UK announced largest ever health research programme to transform the prevention, detection and treatment of diseases
On Jan. 17, 2022, Our Future Health announced the launch of UKï¾’s largest ever health research programme to…
COVAX delivered its 1 billionth COVID-19 vaccine dose
On Jan. 16, 2022, the WHO announced that it had shipped 1.1 million COVID-19 vaccines to Rwanda on…
WHO recommended two new drugs to treat patients with COVID-19
On Jan. 14, 2022, the WHO announced that it had recommended two new drugs for COVID-19, providing yet…
U.S. FDA authorizd InteliSwabï¾™ COVID-19 rapid tests for at-home testing for delta variant detection
On Jan. 13, 2022, OraSure Technologies that its InteliSwabï¾® COVID-19 rapid tests detected the Omicron variant as effectively…
CDC study showed flu vaccination prevented severe flu Illness in U.S. children
On Jan. 13, 2022, the Centers for Disease Control and Prevention announced a study published in the journal…
BioNTech and InstaDeep developed and successfully tested early warning system to detect high-risk SARS-CoV-2 variants
On Jan. 11, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration had expanded the…
GSK and Vir Biotech announced U.S. government purchase of sotrovimab for treatment of COVID-19
On Jan. 11, 2022, GlaxoSmithKline and Vir Biotechnology announced the US Government had purchased an additional 600,000 doses…
Novartis and Molecular Partners reported positive topline data from Phase 2 study for ensovibep antiviral therapeutic for COVID-19
On Jan. 10, 2022, Novartis Molecular Partners announced that Part A of the EMPATHY clinical trial that compared…